|Articles|January 1, 2008
Two-hour MRSA blood test approved
Advertisement
FDA News
On January 2, the Food and Drug Administration (FDA) approved a two-hour staph blood test, which can detect 100% of dangerous specimens and 98% of more commonplace bacteria.
The test, Becton Dickinson's BD GeneOhm StaphSR Assay, is designed to test for methicillin-resistant Staphylococcus aureus (MRSA). Previous tests could take days to deliver results. BD has also submitted paperwork for tests based on nasal swabs and wound claims.
The panel tests for 12 viruses and viral subtypes, including influenza A, human metapneumovirus, and adenovirus. The test is currently available.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
2
New sunscreen ingredient clears FDA for the first time since the 1990s
3
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5